Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
B 12.05 3.43% 0.40
AUPH closed up 3.43 percent on Friday, May 20, 2022, on 1.11 times normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Overbought Stochastic Strength 0.00%
Crossed Above 50 DMA Bullish 3.43%
Overbought Stochastic Strength 3.43%
Fell Below 50 DMA Bearish 7.49%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 7.49%
Calm After Storm Range Contraction 7.49%
Narrow Range Bar Range Contraction 7.49%
NR7 Range Contraction 7.49%
NR7-2 Range Contraction 7.49%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% 2 days ago
60 Minute Opening Range Breakout 2 days ago
Rose Above Previous Day's High 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Life Sciences Drugs Clinical Development Autoimmune Disease Peptides Lupus Immunosuppressants Nephrology Lupus Nephritis Nephritis

Is AUPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.97
52 Week Low 8.86
Average Volume 2,067,579
200-Day Moving Average 17.89
50-Day Moving Average 11.42
20-Day Moving Average 10.83
10-Day Moving Average 10.82
Average True Range 0.91
RSI 55.75
ADX 20.1
+DI 24.91
-DI 17.09
Chandelier Exit (Long, 3 ATRs) 9.39
Chandelier Exit (Short, 3 ATRs) 11.58
Upper Bollinger Bands 12.28
Lower Bollinger Band 9.37
Percent B (%b) 0.92
BandWidth 26.85
MACD Line -0.04
MACD Signal Line -0.28
MACD Histogram 0.2349
Fundamentals Value
Market Cap 1.52 Billion
Num Shares 126 Million
EPS -0.70
Price-to-Earnings (P/E) Ratio -17.29
Price-to-Sales 13945.98
Price-to-Book 4.65
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.49
Resistance 3 (R3) 13.35 12.73 13.25
Resistance 2 (R2) 12.73 12.36 12.80 13.17
Resistance 1 (R1) 12.39 12.14 12.56 12.53 13.09
Pivot Point 11.77 11.77 11.86 11.84 11.77
Support 1 (S1) 11.43 11.40 11.60 11.57 11.01
Support 2 (S2) 10.81 11.18 10.88 10.93
Support 3 (S3) 10.47 10.81 10.85
Support 4 (S4) 10.61